Repositorio de Reportes de Biopsias Oncológicas
0.3.2 - trial-use Chile flag

This page is part of the Repositorio de Reportes de Biopsias Oncológicas (v0.3.2: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

ValueSet: Set de Valores CIE-11 Códigos de Extensión Histopatológicos

Official URL: https://interoperabilidad.minsal.cl/fhir/ig/r2bo/ValueSet/r2bo-morfologicos-cie11-VS Version: 0.3.2
Active as of 2026-09-14 Computable Name: MorfologicoCIE11VS
Other Identifiers: OID:2.16.840.1.113883.2.22.40.8.48.8

Set de valores utilizados para CIE-11 Códigos de Extensión Histopatológicos par ser usado en la morfología de neoplasias

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

  • Include codes fromhttp://id.who.int/icd/release/11/mms version Not Stated (use latest from terminology server) where concept descends from 411368752 (Histopathology) and classKind = category

 

Expansion

Expansion from tx.hl7chile.cl based on codesystem International Classification of Diseases, 11th Revision Mortality and Morbidity Statistics (MMS) version 2026-01-17

This value set has 1.700 codes in it. In order to keep the publication size manageable, only a selection (1.000 codes) of the whole set of codes is shown.

SystemCodeDisplay (en)JSONXML
http://id.who.int/icd/release/11/mms  XH96Q1Acinar cell adenoma
http://id.who.int/icd/release/11/mms  XH3PG9Acinar cell carcinoma
http://id.who.int/icd/release/11/mms  XH99S4Acinar cell cystadenocarcinoma
http://id.who.int/icd/release/11/mms  XH9B93Mixed acinar-ductal carcinoma
http://id.who.int/icd/release/11/mms  XH0F68Acinar adenocarcinoma of the lung
http://id.who.int/icd/release/11/mms  XH2SK9Acinar cell tumour
http://id.who.int/icd/release/11/mms  XH9574Acidophil adenoma
http://id.who.int/icd/release/11/mms  XH3DV3Adenoma, NOS
http://id.who.int/icd/release/11/mms  XH1CV4Adenomatous polyposis coli
http://id.who.int/icd/release/11/mms  XH1YP0Adrenal cortical adenoma, clear cell
http://id.who.int/icd/release/11/mms  XH2CT2Adrenal cortical adenoma, compact cell
http://id.who.int/icd/release/11/mms  XH60N5Adrenal cortical adenoma, glomerulosa cell
http://id.who.int/icd/release/11/mms  XH2VZ8Adrenal cortical adenoma, mixed cell
http://id.who.int/icd/release/11/mms  XH2FJ6Adrenal cortical adenoma, pigmented
http://id.who.int/icd/release/11/mms  XH9356Alveolar adenoma
http://id.who.int/icd/release/11/mms  XH60D1Basal cell adenoma
http://id.who.int/icd/release/11/mms  XH3AH8Basophil adenoma
http://id.who.int/icd/release/11/mms  XH6KR6Bile duct adenoma
http://id.who.int/icd/release/11/mms  XH0778Bile duct cystadenoma
http://id.who.int/icd/release/11/mms  XH7BS0Biliary intraepithelial neoplasia, low grade
http://id.who.int/icd/release/11/mms  XH5YG5Biliary papillomatosis
http://id.who.int/icd/release/11/mms  XH1TD7Canalicular adenoma
http://id.who.int/icd/release/11/mms  XH6WK1Chief cell adenoma
http://id.who.int/icd/release/11/mms  XH7475Chromophobe adenoma
http://id.who.int/icd/release/11/mms  XH9JJ4Clear cell adenofibroma
http://id.who.int/icd/release/11/mms  XH8R87Clear cell adenoma
http://id.who.int/icd/release/11/mms  XH6J91Cylindroma of skin
http://id.who.int/icd/release/11/mms  XH5GN1Eccrine dermal cylindroma
http://id.who.int/icd/release/11/mms  XH6685Embryonal adenoma
http://id.who.int/icd/release/11/mms  XH3K13Oesophageal glandular dysplasia (intraepithelial neoplasia), low grade
http://id.who.int/icd/release/11/mms  XH83X4Flat adenoma
http://id.who.int/icd/release/11/mms  XH0LM0Follicular adenoma
http://id.who.int/icd/release/11/mms  XH5SM2Follicular adenoma, oxyphilic cell
http://id.who.int/icd/release/11/mms  XH6AF9Glandular intraepithelial neoplasia, low grade
http://id.who.int/icd/release/11/mms  XH3BK2Glandular papilloma
http://id.who.int/icd/release/11/mms  XH6PG8Hurthle cell adenoma
http://id.who.int/icd/release/11/mms  XH5X53Hurthle cell tumour
http://id.who.int/icd/release/11/mms  XH6M13Juxtaglomerular tumour
http://id.who.int/icd/release/11/mms  XH0W31Lactating adenoma
http://id.who.int/icd/release/11/mms  XH8P28Lipoadenoma
http://id.who.int/icd/release/11/mms  XH68V1Liver cell adenoma
http://id.who.int/icd/release/11/mms  XH19E3Macrofollicular adenoma
http://id.who.int/icd/release/11/mms  XH0JC7Metanephric adenoma
http://id.who.int/icd/release/11/mms  XH3DH3Microcystic adenoma
http://id.who.int/icd/release/11/mms  XH5LD9Mixed acidophil-basophil adenoma
http://id.who.int/icd/release/11/mms  XH0WV8Mixed adenomatous and hyperplastic polyp
http://id.who.int/icd/release/11/mms  XH1XU4Mixed cell adenoma
http://id.who.int/icd/release/11/mms  XH2CQ8Monomorphic adenoma
http://id.who.int/icd/release/11/mms  XH6CZ4Multiple adenomatous polyps
http://id.who.int/icd/release/11/mms  XH9Z86Oxyphilic adenoma
http://id.who.int/icd/release/11/mms  XH0BF2Pancreatobiliary neoplasm, non-invasive
http://id.who.int/icd/release/11/mms  XH6GG6Pancreatic microadenoma
http://id.who.int/icd/release/11/mms  XH1BH4Papillomatosis, glandular
http://id.who.int/icd/release/11/mms  XH6EJ4Papillotubular adenoma
http://id.who.int/icd/release/11/mms  XH1QS0Lactotroph adenoma
http://id.who.int/icd/release/11/mms  XH5903Serrated adenoma
http://id.who.int/icd/release/11/mms  XH9G87Trabecular adenoma
http://id.who.int/icd/release/11/mms  XH8T50Turban tumour
http://id.who.int/icd/release/11/mms  XH0731Villous papilloma
http://id.who.int/icd/release/11/mms  XH8UC1Water-clear cell adenoma
http://id.who.int/icd/release/11/mms  XH28X1Cylindroma of breast
http://id.who.int/icd/release/11/mms  XH8MU5Adenomatous polyp, NOS
http://id.who.int/icd/release/11/mms  XH7SY6Tubular adenoma, NOS
http://id.who.int/icd/release/11/mms  XH2F06Sessile serrated adenoma
http://id.who.int/icd/release/11/mms  XH63V9Sessile serrated polyp
http://id.who.int/icd/release/11/mms  XH9PD9Traditional sessile serrated adenoma
http://id.who.int/icd/release/11/mms  XH5QL3Atypical adenomatous hyperplasia
http://id.who.int/icd/release/11/mms  XH09B0Papillary adenoma, NOS
http://id.who.int/icd/release/11/mms  XH90D6Villous adenoma, NOS
http://id.who.int/icd/release/11/mms  XH10B0Tubulovillous adenoma, NOS
http://id.who.int/icd/release/11/mms  XH94U0Pituitary adenoma, NOS
http://id.who.int/icd/release/11/mms  XH26P7Spindle cell oncocytoma
http://id.who.int/icd/release/11/mms  XH52F6Adrenal cortical adenoma, NOS
http://id.who.int/icd/release/11/mms  XH6ZD0Endometrioid adenoma, NOS
http://id.who.int/icd/release/11/mms  XH1CX5Endometrioid adenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH2H83Microfollicular adenoma, NOS
http://id.who.int/icd/release/11/mms  XH7DU3Adenoma, intestinal type
http://id.who.int/icd/release/11/mms  XH1Q16Pancreatic neuroendocrine microadenoma
http://id.who.int/icd/release/11/mms  XH8NK5Oncocytic papillary cystadenoma
http://id.who.int/icd/release/11/mms  XH8Y40Null cell adenoma
http://id.who.int/icd/release/11/mms  XH1JL3Plurihormonal adenoma
http://id.who.int/icd/release/11/mms  XH50K4Gonadotroph adenoma
http://id.who.int/icd/release/11/mms  XH4HE3Somatotroph adenoma
http://id.who.int/icd/release/11/mms  XH0MY4Thyrotroph adenoma
http://id.who.int/icd/release/11/mms  XH5RH2Pituitary adenoma, ectopic
http://id.who.int/icd/release/11/mms  XH1C58Corticotroph adenoma
http://id.who.int/icd/release/11/mms  XH7743Bronchiolar adenoma / Ciliated muconodular papillary tumour
http://id.who.int/icd/release/11/mms  XH2L30Adenocarcinoma in situ, NOS
http://id.who.int/icd/release/11/mms  XH4J07Adenocarcinoma in situ in adenomatous polyp
http://id.who.int/icd/release/11/mms  XH3770Adenocarcinoma in situ in tubulovillous adenoma
http://id.who.int/icd/release/11/mms  XH8TV2Adenocarcinoma in situ in villous adenoma
http://id.who.int/icd/release/11/mms  XH5U91Biliary intraepithelial neoplasia, high grade
http://id.who.int/icd/release/11/mms  XH7Y32Cribriform carcinoma in situ
http://id.who.int/icd/release/11/mms  XH0557Ductal carcinoma in situ, solid type
http://id.who.int/icd/release/11/mms  XH36M5Oesophageal glandular dysplasia (intraepithelial neoplasia), high grade
http://id.who.int/icd/release/11/mms  XH5161Flat intraepithelial glandular neoplasia, high grade
http://id.who.int/icd/release/11/mms  XH28N7Glandular intraepithelial neoplasia, high grade
http://id.who.int/icd/release/11/mms  XH26M2Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH5C49Prostatic intraepithelial neoplasia, grade III
http://id.who.int/icd/release/11/mms  XH1FR9Adenocarcinoma in situ of lung, non-mucinous
http://id.who.int/icd/release/11/mms  XH6BU6Adenocarcinoma in situ of lung, mucinous
http://id.who.int/icd/release/11/mms  XH4Z68Endometrioid intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH2QZ6Acidophil carcinoma
http://id.who.int/icd/release/11/mms  XH5LA4Adenocarcinoid tumour
http://id.who.int/icd/release/11/mms  XH74S1Adenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH7QZ0Adenocarcinoma in adenomatous polyp
http://id.who.int/icd/release/11/mms  XH2ZH8Adenocarcinoma in adenomatous polyposis coli
http://id.who.int/icd/release/11/mms  XH9YR3Adenocarcinoma in multiple adenomatous polyps
http://id.who.int/icd/release/11/mms  XH7QB1Adenocarcinoma in tubulovillous adenoma
http://id.who.int/icd/release/11/mms  XH6DA5Adenocarcinoma in villous adenoma
http://id.who.int/icd/release/11/mms  XH5RE1Adenocarcinoma of anal glands
http://id.who.int/icd/release/11/mms  XH2ZQ0Adenocarcinoma with mixed subtypes
http://id.who.int/icd/release/11/mms  XH0349Adenocarcinoma, intestinal type
http://id.who.int/icd/release/11/mms  XH8B45Solid carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH8DS0Neuroendocrine tumour, NOS
http://id.who.int/icd/release/11/mms  XH8LX8Neuroendocrine carcinoma, low grade
http://id.who.int/icd/release/11/mms  XH55D7Neuroendocrine carcinoma, well-differentiated
http://id.who.int/icd/release/11/mms  XH9LV8Neuroendocrine tumor, grade 1
http://id.who.int/icd/release/11/mms  XH7NM1Enterochromaffin cell carcinoid
http://id.who.int/icd/release/11/mms  XH0U20Neuroendocrine carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH7F73Neuroendocrine carcinoma, moderately differentiated
http://id.who.int/icd/release/11/mms  XH24W2Lepidic adenocarcinoma
http://id.who.int/icd/release/11/mms  XH3QM0Minimally invasive adenocarcinoma, Non-mucinous
http://id.who.int/icd/release/11/mms  XH4302Adenoid cystic carcinoma
http://id.who.int/icd/release/11/mms  XH2098Minimally invasive adenocarcinoma, Mucinous
http://id.who.int/icd/release/11/mms  XH6LV9Papillary adenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH95U1Villoglandular carcinoma
http://id.who.int/icd/release/11/mms  XH6QG3Micropapillary carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH4MW7Micropapillary adenocarcinoma
http://id.who.int/icd/release/11/mms  XH7KL6Pituitary carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH6L02Clear cell adenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH5085Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH1442MiT Family translocation carcinomas
http://id.who.int/icd/release/11/mms  XH8EN1Succinate dehydrogenase deficient renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH07X3Alveolar adenocarcinoma
http://id.who.int/icd/release/11/mms  XH05V6Renal cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH3Z08Renal cell carcinoma, unclassified
http://id.who.int/icd/release/11/mms  XH0RU3Acquired cystic disease associated renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH7K79Tubulocystic renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH1VB1Hybrid oncocytic chromophobe tumour
http://id.who.int/icd/release/11/mms  XH3Z50Follicular carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH9508Endometrioid adenocarcinoma, ciliated cell variant
http://id.who.int/icd/release/11/mms  XH0718Endometrioid adenocarcinoma, secretory variant
http://id.who.int/icd/release/11/mms  XH4KH2Adrenal cortical carcinoma
http://id.who.int/icd/release/11/mms  XH0SD2Endometrioid adenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH51K1Neuroendocrine tumour, grade 2
http://id.who.int/icd/release/11/mms  XH09B7Endometrioid cystadenocarcinoma
http://id.who.int/icd/release/11/mms  XH6KR7Endometrioid adenofibroma, malignant
http://id.who.int/icd/release/11/mms  XH0GS9Adenocarcinoma, endocervical type
http://id.who.int/icd/release/11/mms  XH8SF8Islet cell adenomatosis
http://id.who.int/icd/release/11/mms  XH43E4Perihilar cholangiocarcinoma
http://id.who.int/icd/release/11/mms  XH4BY1Islet cell adenoma
http://id.who.int/icd/release/11/mms  XH3CU4Villoglandular variant of endometrioid adenocarcinoma
http://id.who.int/icd/release/11/mms  XH5QV8Pituitary blastoma
http://id.who.int/icd/release/11/mms  XH0Y80Follicular carcinoma, encapsulated, angioinvasive
http://id.who.int/icd/release/11/mms  XH46F1Clear cell renal cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH9SA7Basal cell adenocarcinoma
http://id.who.int/icd/release/11/mms  XH85C2Endolymphatic sac tumor
http://id.who.int/icd/release/11/mms  XH4PB1Acinar adenocarcinoma of prostate
http://id.who.int/icd/release/11/mms  XH8E54Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)
http://id.who.int/icd/release/11/mms  XH5QW8Neuroendocrine tumour, grade 3
http://id.who.int/icd/release/11/mms  XH1NL5Nesidioblastoma
http://id.who.int/icd/release/11/mms  XH5XB7Islet cell carcinoma
http://id.who.int/icd/release/11/mms  XH2ST7Islet cell tumor, NOS
http://id.who.int/icd/release/11/mms  XH4SH8Insulinoma, NOS
http://id.who.int/icd/release/11/mms  XH93H8Gastrinoma
http://id.who.int/icd/release/11/mms  XH7JQ0Parathyroid carcinoma
http://id.who.int/icd/release/11/mms  XH9LV7Basophil carcinoma
http://id.who.int/icd/release/11/mms  XH7152Glucagon-like peptide-producing tumour
http://id.who.int/icd/release/11/mms  XH7LW9L-cell tumour
http://id.who.int/icd/release/11/mms  XH9ZS8Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumour
http://id.who.int/icd/release/11/mms  XH4NQ8Glucagonoma
http://id.who.int/icd/release/11/mms  XH2PF0Enteroglucagonoma
http://id.who.int/icd/release/11/mms  XH72E5Vipoma
http://id.who.int/icd/release/11/mms  XH5VH0Somatostatinoma
http://id.who.int/icd/release/11/mms  XH41P2Endocrine tumour, functioning, NOS
http://id.who.int/icd/release/11/mms  XH7AG8ACTH-producing tumour
http://id.who.int/icd/release/11/mms  XH60V1Medullary thyroid carcinoma
http://id.who.int/icd/release/11/mms  XH3BU6Bile duct cystadenocarcinoma
http://id.who.int/icd/release/11/mms  XH2MW1Medullary carcinoma with amyloid stroma
http://id.who.int/icd/release/11/mms  XH8VU6Poorly differentiated thyroid carcinoma
http://id.who.int/icd/release/11/mms  XH4NH4Pituitary neuroendocrine tumour
http://id.who.int/icd/release/11/mms  XH2ZA2Bronchial adenoma, carcinoid
http://id.who.int/icd/release/11/mms  XH5TR7Adenocarcinoma of lung, mixed mucinous and non-mucinous
http://id.who.int/icd/release/11/mms  XH7GY6Adenocarcinoma of lung, mucinous
http://id.who.int/icd/release/11/mms  XH2035Bronchiolo-alveolar carcinoma, non-mucinous
http://id.who.int/icd/release/11/mms  XH6LF9Carcinoma simplex
http://id.who.int/icd/release/11/mms  XH0XL5Carcinoma, diffuse type
http://id.who.int/icd/release/11/mms  XH7M15Cholangiocarcinoma
http://id.who.int/icd/release/11/mms  XH7SS7Chromophobe carcinoma
http://id.who.int/icd/release/11/mms  XH2Q13Clear cell adenocarcinofibroma
http://id.who.int/icd/release/11/mms  XH6YS0Clear cell adenocarcinoma, mesonephroid
http://id.who.int/icd/release/11/mms  XH4SQ4Collecting duct carcinoma
http://id.who.int/icd/release/11/mms  XH7QJ6Combined hepatocellular carcinoma and cholangiocarcinoma
http://id.who.int/icd/release/11/mms  XH4KK0Cyst-associated renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH0LH8Enterochromaffin-like cell tumour
http://id.who.int/icd/release/11/mms  XH5P16Fetal adenocarcinoma
http://id.who.int/icd/release/11/mms  XH7TE3Follicular adenocarcinoma, moderately differentiated
http://id.who.int/icd/release/11/mms  XH0VD1Follicular adenocarcinoma, trabecular
http://id.who.int/icd/release/11/mms  XH8FK7Follicular adenocarcinoma, well differentiated
http://id.who.int/icd/release/11/mms  XH3DN7Follicular carcinoma, minimally invasive
http://id.who.int/icd/release/11/mms  XH90N9Follicular carcinoma, oxyphilic cell
http://id.who.int/icd/release/11/mms  XH3XT5Glycogen-rich carcinoma
http://id.who.int/icd/release/11/mms  XH4262Goblet cell carcinoid
http://id.who.int/icd/release/11/mms  XH2EH4Granular cell carcinoma
http://id.who.int/icd/release/11/mms  XH4T58Hepatocellular carcinoma, clear cell type
http://id.who.int/icd/release/11/mms  XH9Q35Hepatocellular carcinoma, fibrolamellar
http://id.who.int/icd/release/11/mms  XH0G90Hepatocellular carcinoma, pleomorphic type
http://id.who.int/icd/release/11/mms  XH5761Hepatocellular carcinoma, scirrhous
http://id.who.int/icd/release/11/mms  XH3T17Hepatocellular carcinoma, spindle cell variant
http://id.who.int/icd/release/11/mms  XH6YH5Hurthle cell adenocarcinoma
http://id.who.int/icd/release/11/mms  XH8MQ3Hurthle cell carcinoma
http://id.who.int/icd/release/11/mms  XH8WM4Linitis plastica
http://id.who.int/icd/release/11/mms  XH6TK0Lipid-rich carcinoma
http://id.who.int/icd/release/11/mms  XH81N8Merkel cell carcinoma
http://id.who.int/icd/release/11/mms  XH7019Mixed acidophil-basophil carcinoma
http://id.who.int/icd/release/11/mms  XH8EZ3Mixed acinar-endocrine carcinoma
http://id.who.int/icd/release/11/mms  XH74Y9Mixed acinar-endocrine-ductal carcinoma
http://id.who.int/icd/release/11/mms  XH6H10Mixed adenoneuroendocrine carcinoma
http://id.who.int/icd/release/11/mms  XH2AM6Mixed cell adenocarcinoma
http://id.who.int/icd/release/11/mms  XH7CY5Mixed ductal-endocrine carcinoma
http://id.who.int/icd/release/11/mms  XH6UP4Mixed endocrine and exocrine adenocarcinoma
http://id.who.int/icd/release/11/mms  XH7DG7Mixed medullary-follicular carcinoma
http://id.who.int/icd/release/11/mms  XH3340Mixed medullary-papillary carcinoma
http://id.who.int/icd/release/11/mms  XH9LZ7Mixed pancreatic endocrine and exocrine tumour, malignant
http://id.who.int/icd/release/11/mms  XH1108Nonencapsulated sclerosing carcinoma
http://id.who.int/icd/release/11/mms  XH09D6Oxyphilic adenocarcinoma
http://id.who.int/icd/release/11/mms  XH3614Islet cell adenocarcinoma
http://id.who.int/icd/release/11/mms  XH3709Pancreatic neuroendocrine tumor, nonfunctioning
http://id.who.int/icd/release/11/mms  XH6XY9Pancreatobiliary-type carcinoma
http://id.who.int/icd/release/11/mms  XH1ND9Papillary carcinoma of thyroid
http://id.who.int/icd/release/11/mms  XH85E5Papillary carcinoma, columnar cell
http://id.who.int/icd/release/11/mms  XH0426Papillary carcinoma, diffuse sclerosing
http://id.who.int/icd/release/11/mms  XH0Q59Papillary carcinoma, encapsulated, of thyroid
http://id.who.int/icd/release/11/mms  XH29M4Papillary carcinoma, follicular variant
http://id.who.int/icd/release/11/mms  XH5YT2Papillary carcinoma, oncocytic variant
http://id.who.int/icd/release/11/mms  XH2AW7Papillary microcarcinoma
http://id.who.int/icd/release/11/mms  XH1D07Papillary renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH4Q20Papillotubular adenocarcinoma
http://id.who.int/icd/release/11/mms  XH1JZ0Parietal cell carcinoma
http://id.who.int/icd/release/11/mms  XH6153Renal cell carcinoma, chromophobe type
http://id.who.int/icd/release/11/mms  XH9DH7Renal cell carcinoma, sarcomatoid
http://id.who.int/icd/release/11/mms  XH4FS4Scirrhous adenocarcinoma
http://id.who.int/icd/release/11/mms  XH34G3Solid carcinoma with mucin formation
http://id.who.int/icd/release/11/mms  XH0JE3Superficial spreading adenocarcinoma
http://id.who.int/icd/release/11/mms  XH7EX3Trabecular adenocarcinoma
http://id.who.int/icd/release/11/mms  XH4TA4Tubular adenocarcinoma
http://id.who.int/icd/release/11/mms  XH1Z69Typical carcinoid
http://id.who.int/icd/release/11/mms  XH22Z8Carcinoma of Skene, Cowper and Littre Glands
http://id.who.int/icd/release/11/mms  XH0X20Villous adenocarcinoma
http://id.who.int/icd/release/11/mms  XH0A57Water-clear cell adenocarcinoma
http://id.who.int/icd/release/11/mms  XH8UE4Adenocarcinoma, metastatic, NOS
http://id.who.int/icd/release/11/mms  XH4ZC3Basal cell carcinoma of the prostate
http://id.who.int/icd/release/11/mms  XH4W48Hepatocellular carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH81Q9Bronchial adenoma, cylindroid
http://id.who.int/icd/release/11/mms  XH92Y9Thymic carcinoma with adenoid cystic carcinoma-like features
http://id.who.int/icd/release/11/mms  XH1YZ3Cribriform carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH4YG1Cribriform comedo-type carcinoma
http://id.who.int/icd/release/11/mms  XH74B2Serrated adenocarcinoma
http://id.who.int/icd/release/11/mms  XH6770Apudoma
http://id.who.int/icd/release/11/mms  XH6VL9Atypical adenoma
http://id.who.int/icd/release/11/mms  XH3T38Atypical follicular adenoma
http://id.who.int/icd/release/11/mms  XH0S86Clear cell adenofibroma of borderline malignancy
http://id.who.int/icd/release/11/mms  XH5DQ2Endometrioid adenoma, borderline malignancy
http://id.who.int/icd/release/11/mms  XH76W6Multiple endocrine adenomas
http://id.who.int/icd/release/11/mms  XH8468Pulmonary adenomatosis
http://id.who.int/icd/release/11/mms  XH54H3Hypernephroid tumour
http://id.who.int/icd/release/11/mms  XH7PR9Multilocular cystic renal neoplasm of low malignant potential
http://id.who.int/icd/release/11/mms  XH9DS4Endometrioid adenofibroma, borderline malignancy
http://id.who.int/icd/release/11/mms  XH4JG0Tubular carcinoid
http://id.who.int/icd/release/11/mms  XH4XL2Aggressive papillary tumour
http://id.who.int/icd/release/11/mms  XH9PN4Well differentiated tumor of uncertain malignant potential
http://id.who.int/icd/release/11/mms  XH6SY0Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
http://id.who.int/icd/release/11/mms  XH1Y66Hyalinizing trabecular tumour
http://id.who.int/icd/release/11/mms  XH27W5Follicular tumor of uncertain malignant potential
http://id.who.int/icd/release/11/mms  XH9T60Clear cell papillary renal cell carcinoma
http://id.who.int/icd/release/11/mms  XH6CZ3Clear cell borderline tumour
http://id.who.int/icd/release/11/mms  XH6YZ9Apocrine adenoma
http://id.who.int/icd/release/11/mms  XH0AQ8Clear cell hidradenoma
http://id.who.int/icd/release/11/mms  XH46Z2Eccrine acrospiroma
http://id.who.int/icd/release/11/mms  XH42Z3Eccrine papillary adenoma
http://id.who.int/icd/release/11/mms  XH25Z9Eccrine poroma
http://id.who.int/icd/release/11/mms  XH3AM1Spiradenoma, NOS
http://id.who.int/icd/release/11/mms  XH4YU8Follicular fibroma
http://id.who.int/icd/release/11/mms  XH7NR3Hidrocystoma
http://id.who.int/icd/release/11/mms  XH4MV7Hidradenoma, NOS
http://id.who.int/icd/release/11/mms  XH4DX4Papillary hidradenoma
http://id.who.int/icd/release/11/mms  XH1PY0Syringocystadenoma papilliferum
http://id.who.int/icd/release/11/mms  XH96Q5Skin appendage adenoma
http://id.who.int/icd/release/11/mms  XH3U61Sweat gland adenoma
http://id.who.int/icd/release/11/mms  XH06Y5Syringofibroadenoma
http://id.who.int/icd/release/11/mms  XH6325Syringoma, NOS
http://id.who.int/icd/release/11/mms  XH9GB7Syringomatous tumour of nipple
http://id.who.int/icd/release/11/mms  XH1NC5Sebaceous adenoma
http://id.who.int/icd/release/11/mms  XH0SH5Sebaceous epithelioma
http://id.who.int/icd/release/11/mms  XH7AL8Ceruminous adenoma
http://id.who.int/icd/release/11/mms  XH8R55Spindle cell predominant trichodiscoma
http://id.who.int/icd/release/11/mms  XH1A80Apocrine poroma
http://id.who.int/icd/release/11/mms  XH8N28Poroma, NOS
http://id.who.int/icd/release/11/mms  XH0QL4Sebaceoma
http://id.who.int/icd/release/11/mms  XH7WE6Porocarcinoma in situ
http://id.who.int/icd/release/11/mms  XH9L77Apocrine adenocarcinoma
http://id.who.int/icd/release/11/mms  XH6FB5Digital papillary adenocarcinoma
http://id.who.int/icd/release/11/mms  XH7VK4Porocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH58E1Malignant eccrine spiradenoma
http://id.who.int/icd/release/11/mms  XH7NK9Hidradenocarcinoma
http://id.who.int/icd/release/11/mms  XH17P2Microcystic adnexal carcinoma
http://id.who.int/icd/release/11/mms  XH89V4Adnexal adenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH5LY3Sweat gland adenocarcinoma
http://id.who.int/icd/release/11/mms  XH4VR2Sebaceous carcinoma
http://id.who.int/icd/release/11/mms  XH8NE4Eccrine adenocarcinoma
http://id.who.int/icd/release/11/mms  XH6Z69Ceruminous adenocarcinoma
http://id.who.int/icd/release/11/mms  XH9C82Malignant neoplasm arising from pre-existing spiradenoma
http://id.who.int/icd/release/11/mms  XH2ZK9Malignant neoplasm arising from pre-existing cylindroma
http://id.who.int/icd/release/11/mms  XH9NW9Malignant neoplasm arising from pre-existing spiradenocylindroma
http://id.who.int/icd/release/11/mms  XH65F9Sialadenoma papilliferum
http://id.who.int/icd/release/11/mms  XH0BE5Syringocystadenocarcinoma papilliferum
http://id.who.int/icd/release/11/mms  XH8BW1Sweat gland tumour, NOS
http://id.who.int/icd/release/11/mms  XH1PG0Intraepidermal epithelioma of Jadassohn
http://id.who.int/icd/release/11/mms  XH5AU2Trichilemmoma
http://id.who.int/icd/release/11/mms  XH6QT9Trichoepithelioma
http://id.who.int/icd/release/11/mms  XH0U05Trichofolliculoma
http://id.who.int/icd/release/11/mms  XH5L76Pilar tumour
http://id.who.int/icd/release/11/mms  XH9E37Pilomatricoma, NOS
http://id.who.int/icd/release/11/mms  XH05Z3Trichogerminoma
http://id.who.int/icd/release/11/mms  XH7CM2Melanocytic matricoma
http://id.who.int/icd/release/11/mms  XH3EY8Pilar sheath acanthoma
http://id.who.int/icd/release/11/mms  XH0489Tumor of follicular infundibulum
http://id.who.int/icd/release/11/mms  XH2K97Trichoblastoma
http://id.who.int/icd/release/11/mms  XH70J2Adenoid basal carcinoma
http://id.who.int/icd/release/11/mms  XH45F3Basal cell carcinoma, fibroepithelial
http://id.who.int/icd/release/11/mms  XH4GJ2Basal cell carcinoma, micronodular
http://id.who.int/icd/release/11/mms  XH2CR0Basal cell carcinoma, nodular
http://id.who.int/icd/release/11/mms  XH2615Basal cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH4C18Basosquamous carcinoma
http://id.who.int/icd/release/11/mms  XH5VK4Infiltrating basal cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH0T12Infiltrating basal cell carcinoma, non-sclerosing
http://id.who.int/icd/release/11/mms  XH67Y4Infiltrating basal cell carcinoma, sclerosing
http://id.who.int/icd/release/11/mms  XH9E93Metatypical carcinoma
http://id.who.int/icd/release/11/mms  XH5NL6Superficial basal cell carcinoma
http://id.who.int/icd/release/11/mms  XH2HE7Pigmented basal cell carcinoma
http://id.who.int/icd/release/11/mms  XH9K96Trichilemmocarcinoma
http://id.who.int/icd/release/11/mms  XH9G49Pilomatrical carcinoma
http://id.who.int/icd/release/11/mms  XH6S67Basal cell carcinoma with adnexal differentiation
http://id.who.int/icd/release/11/mms  XH3DL9Trichoblastic carcinoma
http://id.who.int/icd/release/11/mms  XH8324Trichoblastic carcinosarcoma
http://id.who.int/icd/release/11/mms  XH1JH6Basal cell carcinoma, sarcomatoid
http://id.who.int/icd/release/11/mms  XH8189Basal cell tumour
http://id.who.int/icd/release/11/mms  XH7WJ7Proliferating trichilemmal cyst
http://id.who.int/icd/release/11/mms  XH3U29Capillary haemangioma
http://id.who.int/icd/release/11/mms  XH1GU2Cavernous haemangioma
http://id.who.int/icd/release/11/mms  XH10T4Epithelioid haemangioma
http://id.who.int/icd/release/11/mms  XH0LN3Haemangioendothelioma, benign
http://id.who.int/icd/release/11/mms  XH0553Intramuscular haemangioma
http://id.who.int/icd/release/11/mms  XH2HR3Racemose haemangioma
http://id.who.int/icd/release/11/mms  XH4NS3Venous haemangioma
http://id.who.int/icd/release/11/mms  XH5AW4Haemangioma, NOS
http://id.who.int/icd/release/11/mms  XH37N4Myointimoma
http://id.who.int/icd/release/11/mms  XH1JJ2Angiofibroma, NOS
http://id.who.int/icd/release/11/mms  XH23S6Verrucous keratotic haemangioma
http://id.who.int/icd/release/11/mms  XH4E06Cellular angiofibroma
http://id.who.int/icd/release/11/mms  XH73S9Giant cell angiofibroma
http://id.who.int/icd/release/11/mms  XH2EX4Acquired tufted haemangioma
http://id.who.int/icd/release/11/mms  XH4KP7Angiokeratoma
http://id.who.int/icd/release/11/mms  XH8SM9Cutaneous epithelioid angiomatoid nodule
http://id.who.int/icd/release/11/mms  XH8KN7Atypical vascular lesion
http://id.who.int/icd/release/11/mms  XH9Q71Cherry hemangioma
http://id.who.int/icd/release/11/mms  XH88L5Sinusoidal hemangioma
http://id.who.int/icd/release/11/mms  XH9UU3Microvenular hemangioma
http://id.who.int/icd/release/11/mms  XH9NB0Glomeruloid hemangioma
http://id.who.int/icd/release/11/mms  XH6RP8Spindle cell hemangioma
http://id.who.int/icd/release/11/mms  XH27G6Congenital hemangioma, NOS
http://id.who.int/icd/release/11/mms  XH6RC4Congenital hemangioma, rapidly involuting
http://id.who.int/icd/release/11/mms  XH5427Congenital hemangioma, non-involuting
http://id.who.int/icd/release/11/mms  XH8PD3Hobnail hemangioma
http://id.who.int/icd/release/11/mms  XH4LY5Lobular capillary haemangioma
http://id.who.int/icd/release/11/mms  XH4E71Haemangioendothelioma, malignant
http://id.who.int/icd/release/11/mms  XH6264Hemangiosarcoma
http://id.who.int/icd/release/11/mms  XH36A5Kaposi sarcoma
http://id.who.int/icd/release/11/mms  XH6FJ5Kupffer cell sarcoma
http://id.who.int/icd/release/11/mms  XH3C78Intravascular bronchial alveolar tumour
http://id.who.int/icd/release/11/mms  XH36H7Intimal sarcoma
http://id.who.int/icd/release/11/mms  XH9GF8Epithelioid haemangioendothelioma, NOS
http://id.who.int/icd/release/11/mms  XH4SY7Papillary intralymphatic angioendothelioma
http://id.who.int/icd/release/11/mms  XH6PA4Kaposiform haemangioendothelioma
http://id.who.int/icd/release/11/mms  XH2PS0Spindle cell haemangioendothelioma
http://id.who.int/icd/release/11/mms  XH26F6Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma
http://id.who.int/icd/release/11/mms  XH64U8Retiform haemangioendothelioma
http://id.who.int/icd/release/11/mms  XH8D24Composite haemangioendothelioma
http://id.who.int/icd/release/11/mms  XH2L98Haemangioendothelioma, NOS
http://id.who.int/icd/release/11/mms  XH6810Haemangioblastoma
http://id.who.int/icd/release/11/mms  XH9ZB2Adenolymphoma
http://id.who.int/icd/release/11/mms  XH1TX5Mixed squamous cell and glandular papilloma
http://id.who.int/icd/release/11/mms  XH7J33Lymphadenoma
http://id.who.int/icd/release/11/mms  XH2PY4Adenocarcinoma with squamous metaplasia
http://id.who.int/icd/release/11/mms  XH7873Adenosquamous carcinoma
http://id.who.int/icd/release/11/mms  XH9JP2Epithelial-myoepithelial carcinoma
http://id.who.int/icd/release/11/mms  XH7247Adenocarcinoma with cartilaginous and osseous metaplasia
http://id.who.int/icd/release/11/mms  XH2QL8Adenocarcinoma with spindle cell metaplasia
http://id.who.int/icd/release/11/mms  XH6G98Fibromatosis-like metaplastic carcinoma
http://id.who.int/icd/release/11/mms  XH4GA3Adenocarcinoma with apocrine metaplasia
http://id.who.int/icd/release/11/mms  XH4T39Adenocarcinoma with neuroendocrine differentiation
http://id.who.int/icd/release/11/mms  XH0RD4Metaplastic carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH7MV6Hepatoid adenocarcinoma
http://id.who.int/icd/release/11/mms  XH95Y6Squamoid eccrine ductal carcinoma
http://id.who.int/icd/release/11/mms  XH8XD1Endometrioid carcinoma with squamous differentiation
http://id.who.int/icd/release/11/mms  XH4ZH4Adenomyoma
http://id.who.int/icd/release/11/mms  XH7ZB1Atypical polypoid adenomyoma
http://id.who.int/icd/release/11/mms  XH6YS4Benign cystic nephroma
http://id.who.int/icd/release/11/mms  XH70N8Chondroid syringoma
http://id.who.int/icd/release/11/mms  XH8C13Endometrial stromal nodule
http://id.who.int/icd/release/11/mms  XH3SR2Ossifying renal tumour
http://id.who.int/icd/release/11/mms  XH2KC1Pleomorphic adenoma
http://id.who.int/icd/release/11/mms  XH3470Renomedullary interstitial cell tumour
http://id.who.int/icd/release/11/mms  XH2E97Stromal tumour, benign
http://id.who.int/icd/release/11/mms  XH0533Mixed epithelial and stromal tumour
http://id.who.int/icd/release/11/mms  XH7TJ0Paediatric cystic nephroma
http://id.who.int/icd/release/11/mms  XH5QU1Adenomyoepithelioma, NOS
http://id.who.int/icd/release/11/mms  XH2V57Adenomyoepithelioma, benign
http://id.who.int/icd/release/11/mms  XH9T96Phosphaturic mesenchymal tumour, benign
http://id.who.int/icd/release/11/mms  XH3UD9Pulmonary hamartoma
http://id.who.int/icd/release/11/mms  XH3CQ8Myoepithelioma
http://id.who.int/icd/release/11/mms  XH7AA3Mesenchymoma, benign
http://id.who.int/icd/release/11/mms  XH1SP3Adult cystic nephroma
http://id.who.int/icd/release/11/mms  XH2P15​Mesenchymal hamartoma
http://id.who.int/icd/release/11/mms  XH1WZ6Ectomesenchymal chondromyxoid tumour
http://id.who.int/icd/release/11/mms  XH5544Adenosarcoma
http://id.who.int/icd/release/11/mms  XH1YV7Carcinofibroma
http://id.who.int/icd/release/11/mms  XH42V2Carcinoma ex pleomorphic adenoma
http://id.who.int/icd/release/11/mms  XH2RK1Carcinosarcoma, embryonal
http://id.who.int/icd/release/11/mms  XH2CV3Endometrial stromal sarcoma, high grade
http://id.who.int/icd/release/11/mms  XH1S94Endometrial stromal sarcoma, low grade
http://id.who.int/icd/release/11/mms  XH9HQ1Gastrointestinal stromal tumour
http://id.who.int/icd/release/11/mms  XH2WE3Hepatoblastoma
http://id.who.int/icd/release/11/mms  XH0765Clear cell sarcoma of kidney
http://id.who.int/icd/release/11/mms  XH64D5Malignant chondroid syringoma
http://id.who.int/icd/release/11/mms  XH9M31Malignant cystic nephroma
http://id.who.int/icd/release/11/mms  XH3RF3Rhabdoid tumor, NOS
http://id.who.int/icd/release/11/mms  XH0Y65Mesodermal mixed tumour
http://id.who.int/icd/release/11/mms  XH7ZJ9Mullerian mixed tumour
http://id.who.int/icd/release/11/mms  XH27L5Pancreatoblastoma
http://id.who.int/icd/release/11/mms  XH2FY9Pleuropulmonary blastoma
http://id.who.int/icd/release/11/mms  XH5VH1Pulmonary blastoma
http://id.who.int/icd/release/11/mms  XH1TK5Endometrial stromal sarcoma, NOS
http://id.who.int/icd/release/11/mms  XH49Y5Stromal sarcoma, NOS
http://id.who.int/icd/release/11/mms  XH0V86Mixed tumour, malignant, NOS
http://id.who.int/icd/release/11/mms  XH5QN3Nephroblastoma, NOS
http://id.who.int/icd/release/11/mms  XH0H07Hepatoblastoma, epithelioid
http://id.who.int/icd/release/11/mms  XH33R5Hepatoblastoma, mixed epithelial-mesenchymal
http://id.who.int/icd/release/11/mms  XH2W45Carcinosarcoma, NOS
http://id.who.int/icd/release/11/mms  XH7TL5Adenomyoepithelioma with carcinoma
http://id.who.int/icd/release/11/mms  XH3B27Phosphaturic mesenchymal tumour, malignant
http://id.who.int/icd/release/11/mms  XH43E6Myoepithelial carcinoma
http://id.who.int/icd/release/11/mms  XH9N95Mesenchymoma, malignant
http://id.who.int/icd/release/11/mms  XH42Q2Embryonal sarcoma
http://id.who.int/icd/release/11/mms  XH4VQ1Gastroblastoma
http://id.who.int/icd/release/11/mms  XH5CT2Gastrointestinal autonomic nerve tumour
http://id.who.int/icd/release/11/mms  XH0712Gastrointestinal pacemaker cell tumour
http://id.who.int/icd/release/11/mms  XH1JB4Cystic partially differentiated nephroblastoma
http://id.who.int/icd/release/11/mms  XH10F1Mesoblastic nephroma
http://id.who.int/icd/release/11/mms  XH0G00Sialoblastoma
http://id.who.int/icd/release/11/mms  XH6R49Stromal tumour, NOS
http://id.who.int/icd/release/11/mms  XH4N88Metanephric stromal tumour
http://id.who.int/icd/release/11/mms  XH8747Stromal tumour of uncertain malignant potential
http://id.who.int/icd/release/11/mms  XH8X78Calcifying nested stromal-epithelial tumor
http://id.who.int/icd/release/11/mms  XH2AD1Mesenchymoma, NOS
http://id.who.int/icd/release/11/mms  XH5LL8Primitive non-neural granular cell tumor
http://id.who.int/icd/release/11/mms  XH6ZU1Clear cell cystadenoma
http://id.who.int/icd/release/11/mms  XH55F1Cystic tumour of atrio-ventricular node
http://id.who.int/icd/release/11/mms  XH5232Intraductal papillary-mucinous adenoma
http://id.who.int/icd/release/11/mms  XH4070Intraductal papillary-mucinous tumour with intermediate dysplasia
http://id.who.int/icd/release/11/mms  XH8MD2Intraductal papillary-mucinous tumour with low grade dysplasia
http://id.who.int/icd/release/11/mms  XH8ML6Intraductal papillary-mucinous tumour with moderate dysplasia
http://id.who.int/icd/release/11/mms  XH0556Serous microcystic adenoma
http://id.who.int/icd/release/11/mms  XH38C4Serous surface papilloma
http://id.who.int/icd/release/11/mms  XH5RJ2Cystadenoma, NOS
http://id.who.int/icd/release/11/mms  XH8TJ0Serous cystadenoma, NOS
http://id.who.int/icd/release/11/mms  XH0FM6Papillary cystadenoma, NOS
http://id.who.int/icd/release/11/mms  XH6H73Mucinous cystadenoma, NOS
http://id.who.int/icd/release/11/mms  XH8XL1Mucinous cystic neoplasm with intermediate-grade dysplasia
http://id.who.int/icd/release/11/mms  XH6NK7Mucinous cystic neoplasm with low-grade intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH7K36Mucinous cystic tumour with intermediate dysplasia
http://id.who.int/icd/release/11/mms  XH7834Mucinous cystic tumour with moderate dysplasia
http://id.who.int/icd/release/11/mms  XH0EK3Mucinous cystic neoplasm with low-grade dysplasia
http://id.who.int/icd/release/11/mms  XH8EW6Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH9BE7Seromucinous cystadenoma
http://id.who.int/icd/release/11/mms  XH2M29Mucinous adenoma
http://id.who.int/icd/release/11/mms  XH5RX2Mucous gland adenoma
http://id.who.int/icd/release/11/mms  XH9MS1Papillary cystadenofibroma
http://id.who.int/icd/release/11/mms  XH5E08Intraductal papillary-mucinous carcinoma, non-invasive
http://id.who.int/icd/release/11/mms  XH3MB3Intraductal papillary mucinous neoplasm with high grade dysplasia
http://id.who.int/icd/release/11/mms  XH06M2Mucinous cystadenocarcinoma, non-invasive
http://id.who.int/icd/release/11/mms  XH81P3Mucinous cystic neoplasm with high-grade dysplasia
http://id.who.int/icd/release/11/mms  XH8PZ6Serous intraepithelial carcinoma
http://id.who.int/icd/release/11/mms  XH9DM1Serous borderline tumour, micropapillary variant
http://id.who.int/icd/release/11/mms  XH8NV8Serous tubal intraepithelial carcinoma (STIC)
http://id.who.int/icd/release/11/mms  XH1YW4Serous endometrial intraepithelial carcinoma
http://id.who.int/icd/release/11/mms  XH5WU3Intraductal papillary-mucinous carcinoma, invasive
http://id.who.int/icd/release/11/mms  XH2SE1Intraductal papillary mucinous neoplasm with an associated invasive carcinoma
http://id.who.int/icd/release/11/mms  XH0572Micropapillary serous carcinoma
http://id.who.int/icd/release/11/mms  XH5P21Solid pseudopapillary carcinoma
http://id.who.int/icd/release/11/mms  XH0219Cystadenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH7A08Serous carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH6JU6Papillary cystadenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH12V5Low grade serous carcinoma
http://id.who.int/icd/release/11/mms  XH24N6High grade serous carcinoma
http://id.who.int/icd/release/11/mms  XH1390Mucinous cystadenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH1K19Mucinous cystic tumour with an associated invasive carcinoma
http://id.who.int/icd/release/11/mms  XH4186Seromucinous carcinoma
http://id.who.int/icd/release/11/mms  XH1S75Mucinous adenocarcinoma
http://id.who.int/icd/release/11/mms  XH4U83Pseudomyxoma peritonei with unknown primary site
http://id.who.int/icd/release/11/mms  XH5EQ2Mucinous tubular and spindle cell carcinoma
http://id.who.int/icd/release/11/mms  XH83J5Pseudomyxoma peritonei
http://id.who.int/icd/release/11/mms  XH4KC5Mucinous carcinoma, gastric type
http://id.who.int/icd/release/11/mms  XH56K0Metastatic signet ring cell carcinoma
http://id.who.int/icd/release/11/mms  XH5AF5Mucin-producing adenocarcinoma
http://id.who.int/icd/release/11/mms  XH4546Signet ring cell carcinoma
http://id.who.int/icd/release/11/mms  XH2KK0Poorly cohesive carcinoma
http://id.who.int/icd/release/11/mms  XH3RD4Krukenberg tumour
http://id.who.int/icd/release/11/mms  XH0XE5Signet ring cell/histiocytoid carcinoma
http://id.who.int/icd/release/11/mms  XH3AE9Solid pseudopapillary neoplasm of pancreas
http://id.who.int/icd/release/11/mms  XH2FF0Mucinous cystic tumour of borderline malignancy
http://id.who.int/icd/release/11/mms  XH1P30Papillary cystadenoma, borderline malignancy
http://id.who.int/icd/release/11/mms  XH0RB9Seromucinous borderline tumour
http://id.who.int/icd/release/11/mms  XH3ZK9Serous borderline tumour, NOS
http://id.who.int/icd/release/11/mms  XH3FD4Solid pseudopapillary tumor of ovary
http://id.who.int/icd/release/11/mms  XH7BB4Low grade appendiceal mucinous neoplasm
http://id.who.int/icd/release/11/mms  XH6RX1Intracystic papillary neoplasm with low grade intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH5ZH7Intraductal papillary neoplasm with low grade intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH4LZ4Intraductal papilloma
http://id.who.int/icd/release/11/mms  XH7QS7Intraductal tubular-papillary neoplasm, low grade
http://id.who.int/icd/release/11/mms  XH6HK2Intraductal papillary neoplasm, NOS
http://id.who.int/icd/release/11/mms  XH60S7Intraductal papilloma with atypical ductal hyperplasia
http://id.who.int/icd/release/11/mms  XH7GN3Adenoma of nipple
http://id.who.int/icd/release/11/mms  XH9F80Intracystic papillary adenoma
http://id.who.int/icd/release/11/mms  XH4JD3Intraductal papillomatosis, NOS
http://id.who.int/icd/release/11/mms  XH8P86Comedocarcinoma, noninfiltrating
http://id.who.int/icd/release/11/mms  XH6AH7Intraductal papillary neoplasm with high grade intraepithelial neoplasia
http://id.who.int/icd/release/11/mms  XH9VG0Noninfiltrating intraductal papillary adenocarcinoma
http://id.who.int/icd/release/11/mms  XH1H31Intraductal carcinoma, noninfiltrating, NOS
http://id.who.int/icd/release/11/mms  XH4V32Ductal carcinoma in situ, NOS
http://id.who.int/icd/release/11/mms  XH11S9Intraductal papilloma with DCIS
http://id.who.int/icd/release/11/mms  XH64S7Intraductal tubular-papillary neoplasm, high grade
http://id.who.int/icd/release/11/mms  XH9XV2Noninfiltrating intracystic carcinoma
http://id.who.int/icd/release/11/mms  XH0134Solid papillary carcinoma in situ
http://id.who.int/icd/release/11/mms  XH39X8Intraductal carcinoma, clinging, high grade
http://id.who.int/icd/release/11/mms  XH9SL6Cystic hypersecretory carcinoma, intraductal
http://id.who.int/icd/release/11/mms  XH0GQ3Intraductal micropapillary carcinoma
http://id.who.int/icd/release/11/mms  XH2HB2Lobular carcinoma in situ, pleomorphic
http://id.who.int/icd/release/11/mms  XH6EH0Lobular carcinoma in situ, NOS
http://id.who.int/icd/release/11/mms  XH7XE0Intraductal carcinoma and lobular carcinoma in situ
http://id.who.int/icd/release/11/mms  XH3PE9Intraductal tubulopapillary neoplasm
http://id.who.int/icd/release/11/mms  XH8010Endocrine mucin-producing sweat gland carcinoma in situ
http://id.who.int/icd/release/11/mms  XH4US4Intraductal papilloma with lobular carcinoma in situ
http://id.who.int/icd/release/11/mms  XH44J4Secretory carcinoma
http://id.who.int/icd/release/11/mms  XH7KH3Duct adenocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH9FX2Adenocarcinoma of mammary gland type
http://id.who.int/icd/release/11/mms  XH1N58Comedocarcinoma, NOS
http://id.who.int/icd/release/11/mms  XH8MA7Intraductal papillary adenocarcinoma with invasion
http://id.who.int/icd/release/11/mms  XH8KR8Papillary carcinoma of the breast
http://id.who.int/icd/release/11/mms  XH90W1Intraductal papillary neoplasm with associated invasive carcinoma
http://id.who.int/icd/release/11/mms  XH0GT6Encapsulated papillary carcinoma with invasion
http://id.who.int/icd/release/11/mms  XH9C56Invasive micropapillary carcinoma of breast
http://id.who.int/icd/release/11/mms  XH1XB5Solid papillary carcinoma with invasion
http://id.who.int/icd/release/11/mms  XH2YP5Medullary carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH9B99Medullary-like carcinoma
http://id.who.int/icd/release/11/mms  XH2XR3Lobular carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH9620Medullary adenocarcinoma
http://id.who.int/icd/release/11/mms  XH6KZ1Atypical medullary carcinoma
http://id.who.int/icd/release/11/mms  XH6PY4Duct carcinoma, desmoplastic type
http://id.who.int/icd/release/11/mms  XH55H7Medullary carcinoma with lymphoid stroma
http://id.who.int/icd/release/11/mms  XH3RK9Tubulolobular carcinoma
http://id.who.int/icd/release/11/mms  XH0408Infiltrating ductular carcinoma
http://id.who.int/icd/release/11/mms  XH8RN5Infiltrating duct and lobular carcinoma
http://id.who.int/icd/release/11/mms  XH9Z29Intraductal and lobular carcinoma
http://id.who.int/icd/release/11/mms  XH6MH3Infiltrating duct and lobular carcinoma in situ
http://id.who.int/icd/release/11/mms  XH9551Infiltrating lobular carcinoma and ductal carcinoma in situ
http://id.who.int/icd/release/11/mms  XH8CS0Infiltrating duct mixed with other types of carcinoma
http://id.who.int/icd/release/11/mms  XH9GX4Infiltrating duct and colloid carcinoma
http://id.who.int/icd/release/11/mms  XH2ST9Infiltrating duct and cribriform carcinoma
http://id.who.int/icd/release/11/mms  XH3969Infiltrating duct and mucinous carcinoma
http://id.who.int/icd/release/11/mms  XH1ND7Infiltrating duct and tubular carcinoma
http://id.who.int/icd/release/11/mms  XH3CB4Infiltrating lobular mixed with other types of carcinoma
http://id.who.int/icd/release/11/mms  XH5SD5Polymorphous adenocarcinoma
http://id.who.int/icd/release/11/mms  XH9G73Inflammatory carcinoma
http://id.who.int/icd/release/11/mms  XH3E21Paget disease, mammary
http://id.who.int/icd/release/11/mms  XH47A6Paget disease and infiltrating duct carcinoma of breast
http://id.who.int/icd/release/11/mms  XH70F8Paget disease, extramammary
http://id.who.int/icd/release/11/mms  XH0C76Paget disease and intraductal carcinoma of breast
http://id.who.int/icd/release/11/mms  XH32K6Basal-like carcinoma of breast
http://id.who.int/icd/release/11/mms  XH4ZU9Adenocarcinoma of anogenital mammary-like glands
http://id.who.int/icd/release/11/mms  XH5KW8Carcinoma of male breast
http://id.who.int/icd/release/11/mms  XH4EK4Endocrine mucin-producing sweat gland carcinoma
http://id.who.int/icd/release/11/mms  XH9HB7Lobular carcinoma, pleomorphic
http://id.who.int/icd/release/11/mms  XH1146Juvenile carcinoma of breast
http://id.who.int/icd/release/11/mms  XH8TH6Cystic hypersecretory carcinoma
http://id.who.int/icd/release/11/mms  XH9HV0Epithelial tumour, benign
http://id.who.int/icd/release/11/mms  XH1TD2Tumourlet, benign
http://id.who.int/icd/release/11/mms  XH65S3Epithelioma, benign
http://id.who.int/icd/release/11/mms  XH0M86Focal nodular hyperplasia
http://id.who.int/icd/release/11/mms  XH5NV6Carcinoma in situ, NOS
http://id.who.int/icd/release/11/mms  XH56X7Carcinoma with osteoclast-like giant cells
http://id.who.int/icd/release/11/mms  XH63D2Carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH3XZ6Giant cell and spindle cell carcinoma
http://id.who.int/icd/release/11/mms  XH1JZ2Giant cell carcinoma
http://id.who.int/icd/release/11/mms  XH00N7Glassy cell carcinoma
http://id.who.int/icd/release/11/mms  XH4QU2Large cell carcinoma with rhabdoid phenotype
http://id.who.int/icd/release/11/mms  XH0NL5Large cell neuroendocrine carcinoma
http://id.who.int/icd/release/11/mms  XH35G0Pleomorphic carcinoma
http://id.who.int/icd/release/11/mms  XH92T7Polygonal cell carcinoma
http://id.who.int/icd/release/11/mms  XH35M3Pseudosarcomatous carcinoma
http://id.who.int/icd/release/11/mms  XH1YN3Carcinoma, metastatic, NOS
http://id.who.int/icd/release/11/mms  XH8D74Carcinomatosis
http://id.who.int/icd/release/11/mms  XH4P61Epithelioma, malignant
http://id.who.int/icd/release/11/mms  XH45J4Large cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH1YY4Carcinoma, undifferentiated, NOS
http://id.who.int/icd/release/11/mms  XH57U9Carcinoma, anaplastic, NOS
http://id.who.int/icd/release/11/mms  XH2855Nuclear protein in testis (NUT) associated carcinoma
http://id.who.int/icd/release/11/mms  XH3RZ4Spindle cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH0YB0Small cell carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH9SY0Small cell neuroendocrine carcinoma
http://id.who.int/icd/release/11/mms  XH28J9Oat cell carcinoma
http://id.who.int/icd/release/11/mms  XH3T00Small cell carcinoma, fusiform cell
http://id.who.int/icd/release/11/mms  XH6GK0Small cell carcinoma, intermediate cell
http://id.who.int/icd/release/11/mms  XH8ZR8Small cell carcinoma, hypercalcaemic type
http://id.who.int/icd/release/11/mms  XH7YE3Combined small cell carcinoma
http://id.who.int/icd/release/11/mms  XH0793Combined small cell-adenocarcinoma
http://id.who.int/icd/release/11/mms  XH6FK9Combined small cell-large cell carcinoma
http://id.who.int/icd/release/11/mms  XH9ZD2Combined small cell-squamous cell carcinoma
http://id.who.int/icd/release/11/mms  XH1DU4Non-small cell carcinoma
http://id.who.int/icd/release/11/mms  XH26N1Heterotopia-associated carcinoma
http://id.who.int/icd/release/11/mms  XH90B3Combined large cell neuroendocrine carcinoma
http://id.who.int/icd/release/11/mms  XH98Z7Anaplastic undifferentiated carcinoma
http://id.who.int/icd/release/11/mms  XH5R16Dedifferentiated carcinoma
http://id.who.int/icd/release/11/mms  XH2BS4Squamous carcinoma with osteoclast-like giant cells
http://id.who.int/icd/release/11/mms  XH2224Undifferentiated carcinoma with osteoclast-like giant cells
http://id.who.int/icd/release/11/mms  XH1N44Tumourlet, NOS
http://id.who.int/icd/release/11/mms  XH5DX3Brenner tumour, NOS
http://id.who.int/icd/release/11/mms  XH4MA6Intracanalicular fibroadenoma
http://id.who.int/icd/release/11/mms  XH7JU0Papillary adenofibroma
http://id.who.int/icd/release/11/mms  XH0N11Pericanalicular fibroadenoma
http://id.who.int/icd/release/11/mms  XH9HE2Fibroadenoma, NOS
http://id.who.int/icd/release/11/mms  XH91Y8Adenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH5S99Cystadenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH5ZB5Serous adenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH6RL8Serous cystadenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH1VJ0Seromucinous adenofibroma
http://id.who.int/icd/release/11/mms  XH59X8Mucinous adenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH9SM7Mucinous cystadenofibroma, NOS
http://id.who.int/icd/release/11/mms  XH50P7Phyllodes tumour, benign
http://id.who.int/icd/release/11/mms  XH4RU1Giant fibroadenoma
http://id.who.int/icd/release/11/mms  XH70H4Juvenile fibroadenoma
http://id.who.int/icd/release/11/mms  XH5853Lipofibroadenoma
http://id.who.int/icd/release/11/mms  XH7ZU2Metanephric adenofibroma
http://id.who.int/icd/release/11/mms  XH6NJ7Brenner tumour, malignant
http://id.who.int/icd/release/11/mms  XH7284Mucinous adenocarcinofibroma
http://id.who.int/icd/release/11/mms  XH75P5Periductal stromal tumour, low grade
http://id.who.int/icd/release/11/mms  XH9JC2Serous adenocarcinofibroma
http://id.who.int/icd/release/11/mms  XH6PQ0Serous cystadenocarcinofibroma
http://id.who.int/icd/release/11/mms  XH0WW5Mucinous cystadenocarcinofibroma
http://id.who.int/icd/release/11/mms  XH8HJ7Phyllodes tumour, malignant
http://id.who.int/icd/release/11/mms  XH2CH8Brenner tumour, borderline malignancy
http://id.who.int/icd/release/11/mms  XH7AR7Mucinous adenofibroma of borderline malignancy
http://id.who.int/icd/release/11/mms  XH2YZ1Mucinous cystadenofibroma of borderline malignancy
http://id.who.int/icd/release/11/mms  XH5NK4Phyllodes tumour, borderline
http://id.who.int/icd/release/11/mms  XH07C7Serous adenofibroma of borderline malignancy
http://id.who.int/icd/release/11/mms  XH2M30Serous cystadenofibroma of borderline malignancy
http://id.who.int/icd/release/11/mms  XH8A47Angiomyofibroblastoma
http://id.who.int/icd/release/11/mms  XH06N0Benign fibrous histiocytoma
http://id.who.int/icd/release/11/mms  XH3BQ8Elastofibroma
http://id.who.int/icd/release/11/mms  XH2MW3Fascial fibroma
http://id.who.int/icd/release/11/mms  XH5XQ3Fibromyxoma
http://id.who.int/icd/release/11/mms  XH3NQ0Myofibroblastoma
http://id.who.int/icd/release/11/mms  XH0953Myofibroma
http://id.who.int/icd/release/11/mms  XH7FV0Periosteal fibroma
http://id.who.int/icd/release/11/mms  XH8E66Fibroma, NOS
http://id.who.int/icd/release/11/mms  XH2ZF3Desmoplastic fibroblastoma
http://id.who.int/icd/release/11/mms  XH7GT0Gardner fibroma
http://id.who.int/icd/release/11/mms  XH0XH6Nuchal fibroma
http://id.who.int/icd/release/11/mms  XH2WT6Plexiform fibromyxoma
http://id.who.int/icd/release/11/mms  XH0WB3Fibroma of tendon sheath
http://id.who.int/icd/release/11/mms  XH8Q71Solitary fibrous tumour/Haemangiopericytoma, grade 1
http://id.who.int/icd/release/11/mms  XH7TH6Calcifying fibrous tumour
http://id.who.int/icd/release/11/mms  XH5LM1Nodular fasciitis
http://id.who.int/icd/release/11/mms  XH1UJ5Histiocytoma, NOS
http://id.who.int/icd/release/11/mms  XH8B90Dermatofibroma, NOS
http://id.who.int/icd/release/11/mms  XH7436Sclerosing pneumocytoma
http://id.who.int/icd/release/11/mms  XH5DP4Deep histiocytoma
http://id.who.int/icd/release/11/mms  XH9VG1Juvenile histiocytoma
http://id.who.int/icd/release/11/mms  XH33Q1Reticulohistiocytoma
http://id.who.int/icd/release/11/mms  XH8ZE3Calcifying aponeurotic fibroma
http://id.who.int/icd/release/11/mms  XH2874Collagenous fibroma
http://id.who.int/icd/release/11/mms  XH3665Plaque-like CD34 positive dermal fibroma
http://id.who.int/icd/release/11/mms  XH8173Acral fibromyxoma
http://id.who.int/icd/release/11/mms  XH5JG7Sclerotic fibroma
http://id.who.int/icd/release/11/mms  XH6JX7Proliferative fasciitis
http://id.who.int/icd/release/11/mms  XH87F9Proliferative myositis
http://id.who.int/icd/release/11/mms  XH15M9Epithelioid fibrous histiocytoma
http://id.who.int/icd/release/11/mms  XH1BV2Pleomorphic fibroma
http://id.who.int/icd/release/11/mms  XH18K3Dermatomyofibroma
http://id.who.int/icd/release/11/mms  XH2HE9Myopericytoma
http://id.who.int/icd/release/11/mms  XH5FY2Fibrous dysplasia
http://id.who.int/icd/release/11/mms  XH8EV4Fascial fibrosarcoma
http://id.who.int/icd/release/11/mms  XH6LT0Fibromyxosarcoma
http://id.who.int/icd/release/11/mms  XH7BC6Infantile fibrosarcoma
http://id.who.int/icd/release/11/mms  XH3406Periosteal fibrosarcoma
http://id.who.int/icd/release/11/mms  XH56W2Periosteal sarcoma, NOS
http://id.who.int/icd/release/11/mms  XH1HP3Solitary fibrous tumour, malignant
http://id.who.int/icd/release/11/mms  XH4EP1Fibrosarcoma, NOS
http://id.who.int/icd/release/11/mms  XH1DA3Solitary fibrous tumour/Haemangiopericytoma, grade 3
http://id.who.int/icd/release/11/mms  XH2668Myofibroblastic sarcoma
http://id.who.int/icd/release/11/mms  XH0947Malignant fibrous histiocytoma
http://id.who.int/icd/release/11/mms  XH8WH0Myxofibrosarcoma
http://id.who.int/icd/release/11/mms  XH9V92Dermatofibrosarcoma protuberans, fibrosarcomatous
http://id.who.int/icd/release/11/mms  XH6116Abdominal fibromatosis
http://id.who.int/icd/release/11/mms  XH13Z3Aggressive fibromatosis
http://id.who.int/icd/release/11/mms  XH1RM7Atypical fibrous histiocytoma
http://id.who.int/icd/release/11/mms  XH9HH5Cellular fibroma
http://id.who.int/icd/release/11/mms  XH5MH2Congenital generalised fibromatosis
http://id.who.int/icd/release/11/mms  XH85R1Myofibroblastic tumour, peribronchial
http://id.who.int/icd/release/11/mms  XH1N00Myofibromatosis
http://id.who.int/icd/release/11/mms  XH2D15Myxoinflammatory fibroblastic sarcoma
http://id.who.int/icd/release/11/mms  XH0TA8Atypical myxoinflammatory fibroblastic tumour
http://id.who.int/icd/release/11/mms  XH9526Haemosiderotic fibrolipomatous tumour
http://id.who.int/icd/release/11/mms  XH75J5Palmar/plantar type fibromatosis
http://id.who.int/icd/release/11/mms  XH7E62Solitary fibrous tumour, NOS
http://id.who.int/icd/release/11/mms  XH1EH1Solitary fibrous tumour/Haemangiopericytoma, grade 2
http://id.who.int/icd/release/11/mms  XH66Z0Myofibroblastic tumour, NOS
http://id.who.int/icd/release/11/mms  XH6YK5Desmoplastic fibroma
http://id.who.int/icd/release/11/mms  XH4QZ8Dermatofibrosarcoma protuberans, NOS
http://id.who.int/icd/release/11/mms  XH5CT4Pigmented dermatofibrosarcoma protuberans
http://id.who.int/icd/release/11/mms  XH9AV8Giant cell fibroblastoma
http://id.who.int/icd/release/11/mms  XH4GL1Plexiform fibrohistiocytic tumour
http://id.who.int/icd/release/11/mms  XH9362Angiomatoid fibrous histiocytoma
http://id.who.int/icd/release/11/mms  XH7050Haemangiopericytic meningioma
http://id.who.int/icd/release/11/mms  XH3GV5Teratoma, benign
http://id.who.int/icd/release/11/mms  XH9F67Dermoid cyst, NOS
http://id.who.int/icd/release/11/mms  XH52Q4Teratoma, prepubertal type
http://id.who.int/icd/release/11/mms  XH22M4Struma ovarii, NOS
http://id.who.int/icd/release/11/mms  XH8AD3Intratubular malignant germ cells
http://id.who.int/icd/release/11/mms  XH24E0Dysgerminoma
http://id.who.int/icd/release/11/mms  XH0A34Germ cell tumour, nonseminomatous
http://id.who.int/icd/release/11/mms  XH1E13Germinoma
http://id.who.int/icd/release/11/mms  XH7SG5Hepatoid yolk sac tumour
http://id.who.int/icd/release/11/mms  XH0N49Immature teratoma, malignant
http://id.who.int/icd/release/11/mms  XH2PP9Malignant teratoma, undifferentiated
http://id.who.int/icd/release/11/mms  XH9Z28Polyembryoma
http://id.who.int/icd/release/11/mms  XH6YQ4Seminoma, anaplastic
http://id.who.int/icd/release/11/mms  XH80D1Spermatocytic seminoma
http://id.who.int/icd/release/11/mms  XH56W1Teratocarcinoma
http://id.who.int/icd/release/11/mms  XH09W7Yolk sac tumour
http://id.who.int/icd/release/11/mms  XH9FM4Seminoma, NOS
http://id.who.int/icd/release/11/mms  XH8MB9Embryonal carcinoma, NOS
http://id.who.int/icd/release/11/mms  XH15X1Yolk sac tumour, post pubertal type
http://id.who.int/icd/release/11/mms  XH7YZ9Teratoma, malignant, NOS
http://id.who.int/icd/release/11/mms  XH43T4Malignant teratoma, intermediate
http://id.who.int/icd/release/11/mms  XH33E8Teratoma with malignant transformation
http://id.who.int/icd/release/11/mms  XH2PS1Mixed germ cell tumour
http://id.who.int/icd/release/11/mms  XH9QP9Germ cell tumour with associated haematological malignancy
http://id.who.int/icd/release/11/mms  XH5U02Mixed teratoma and seminoma
http://id.who.int/icd/release/11/mms  XH5PU7Struma ovarii, malignant
http://id.who.int/icd/release/11/mms  XH1P78Teratocarcinosarcoma
http://id.who.int/icd/release/11/mms  XH0K61Gonadoblastoma
http://id.who.int/icd/release/11/mms  XH83G5Teratoma, NOS
http://id.who.int/icd/release/11/mms  XH4NU1Germ cell tumour, regressed
http://id.who.int/icd/release/11/mms  XH5MG2Immature teratoma of the lung
http://id.who.int/icd/release/11/mms  XH2KP9Immature teratoma of the thymus
http://id.who.int/icd/release/11/mms  XH2XW3Strumal carcinoid
http://id.who.int/icd/release/11/mms  XH5PC3Immature teratoma of thyroid
http://id.who.int/icd/release/11/mms  XH6911Tenosynovial giant cell tumour, localised
http://id.who.int/icd/release/11/mms  XH0HZ1Tenosynovial giant cell tumour, NOS
http://id.who.int/icd/release/11/mms  XH0492Giant cell tumour of bone, malignant
http://id.who.int/icd/release/11/mms  XH84X1Malignant giant cell tumour of soft parts
http://id.who.int/icd/release/11/mms  XH4TC2Giant cell tumour of bone, NOS
http://id.who.int/icd/release/11/mms  XH81M1Giant cell tumour of soft parts, NOS
http://id.who.int/icd/release/11/mms  XH52J9Tenosynovial giant cell tumour, diffuse
http://id.who.int/icd/release/11/mms  XH5AQ9Malignant tenosynovial giant cell tumour
http://id.who.int/icd/release/11/mms  XH0RF9Choroid plexus papilloma, NOS
http://id.who.int/icd/release/11/mms  XH0H76Dysembryoplastic neuroepithelial tumour
http://id.who.int/icd/release/11/mms  XH1Q28Sellar ependymoma
http://id.who.int/icd/release/11/mms  XH1DC5Astroblastoma
http://id.who.int/icd/release/11/mms  XH96C7Astrocytoma, anaplastic
http://id.who.int/icd/release/11/mms  XH1S63Astrocytoma, low grade
http://id.who.int/icd/release/11/mms  XH54D9Cellular ependymoma
http://id.who.int/icd/release/11/mms  XH3M77Choroid plexus carcinoma
http://id.who.int/icd/release/11/mms  XH6E51Clear cell ependymoma
http://id.who.int/icd/release/11/mms  XH8W32Diffuse astrocytoma
http://id.who.int/icd/release/11/mms  XH6UY7Diffuse astrocytoma, low grade
http://id.who.int/icd/release/11/mms  XH6922Ependymoma, anaplastic
http://id.who.int/icd/release/11/mms  XH6C35Fibrillary astrocytoma
http://id.who.int/icd/release/11/mms  XH5Y81Gemistocytic astrocytoma
http://id.who.int/icd/release/11/mms  XH4RQ3Glioma, malignant
http://id.who.int/icd/release/11/mms  XH6ZH4Gliomatosis cerebri
http://id.who.int/icd/release/11/mms  XH9RC8Gliosarcoma
http://id.who.int/icd/release/11/mms  XH6F49Oligoastrocytoma, NOS
http://id.who.int/icd/release/11/mms  XH9J28Papillary ependymoma
http://id.who.int/icd/release/11/mms  XH99U2Pleomorphic xanthoastrocytoma
http://id.who.int/icd/release/11/mms  XH6UV4Protoplasmic astrocytoma
http://id.who.int/icd/release/11/mms  XH4BJ4Tanycytic ependymoma
http://id.who.int/icd/release/11/mms  XH7692Diffuse midline glioma, H3 K27M-mutant
http://id.who.int/icd/release/11/mms  XH9YU2Diffuse intrinsic pontine glioma, H3 K27M-mutant
http://id.who.int/icd/release/11/mms  XH1511Ependymoma, NOS
http://id.who.int/icd/release/11/mms  XH2AY7Ependymoma, RELA fusion-positive
http://id.who.int/icd/release/11/mms  XH6PH6Astrocytoma, NOS
http://id.who.int/icd/release/11/mms  XH36Y8Cystic astrocytoma
http://id.who.int/icd/release/11/mms  XH2HK4Diffuse astrocytoma, IDH-mutant
http://id.who.int/icd/release/11/mms  XH7HQ6Astrocytoma, anaplastic, IDH-mutant
http://id.who.int/icd/release/11/mms  XH83Y5Polar spongioblastoma
http://id.who.int/icd/release/11/mms  XH8BK8Anaplastic pleomorphic xanthoastrocytoma
http://id.who.int/icd/release/11/mms  XH7F82Glioblastoma, NOS
http://id.who.int/icd/release/11/mms  XH5571Glioblastoma, IDH-wild type
http://id.who.int/icd/release/11/mms  XH0MB1Glioblastoma, primary, NOS
http://id.who.int/icd/release/11/mms  XH3N49Diffuse midline glioma, NOS
http://id.who.int/icd/release/11/mms  XH61Y5Diffuse intrinsic pontine glioma
http://id.who.int/icd/release/11/mms  XH4FN3Glioblastoma, IDH mutant
http://id.who.int/icd/release/11/mms  XH17J4Glioblastoma, secondary, NOS
http://id.who.int/icd/release/11/mms  XH7W59Oligodendroglioma, NOS
http://id.who.int/icd/release/11/mms  XH7K31Oligodendroglioma, IDH-mutant and 1p/19q co deleted
http://id.who.int/icd/release/11/mms  XH9QF3Oligodendroglioma, anaplastic, IDH mutant and 1p/19q co deleted
http://id.who.int/icd/release/11/mms  XH7CX7Oligodendroblastoma
http://id.who.int/icd/release/11/mms  XH8P29Medulloblastoma, NOS
http://id.who.int/icd/release/11/mms  XH9M38Medulloblastoma, SHH-activated and TP53-wild type
http://id.who.int/icd/release/11/mms  XH8844Oligodendroglioma, anaplastic
http://id.who.int/icd/release/11/mms  XH4B47Melanotic medulloblastoma
http://id.who.int/icd/release/11/mms  XH6JN6Medulloblastoma with extensive nodularity
http://id.who.int/icd/release/11/mms  XH85M7Medulloblastoma, SHH activated, NOS
http://id.who.int/icd/release/11/mms  XH8SH6CNS embryonal tumour, NOS
http://id.who.int/icd/release/11/mms  XH89C3Central primitive neuroectodermal tumour
http://id.who.int/icd/release/11/mms  XH3EX1Medulloblastoma, WNT-activated, classic
http://id.who.int/icd/release/11/mms  XH5163Medulloblastoma, WNT-activated, Large cell type
http://id.who.int/icd/release/11/mms  XH2FW8Medulloblastoma, WNT-activated, Anaplastic type
http://id.who.int/icd/release/11/mms  XH1SH4Medulloblastoma, SHH-activated and TP53-mutant
http://id.who.int/icd/release/11/mms  XH87Q5Medulloblastoma, non-WNT/non-SHH
http://id.who.int/icd/release/11/mms  XH51C5Embryonal tumours with multilayered rosettes with C19MC alteration
http://id.who.int/icd/release/11/mms  XH0KZ2Embryonal tumour with multilayered rosettes, NOS
http://id.who.int/icd/release/11/mms  XH5538Cerebellar sarcoma, NOS
http://id.who.int/icd/release/11/mms  XH8R14Medullomyoblastoma
http://id.who.int/icd/release/11/mms  XH7Y86Supratentorial PNET
http://id.who.int/icd/release/11/mms  XH5PR7Large cell medulloblastoma
http://id.who.int/icd/release/11/mms  XH0H95Anaplastic medulloblastoma
http://id.who.int/icd/release/11/mms  XH8UC5Giant cell glioblastoma
http://id.who.int/icd/release/11/mms  XH0RY1Classic medulloblastoma
http://id.who.int/icd/release/11/mms  XH7PN5Desmoplastic nodular medulloblastoma
http://id.who.int/icd/release/11/mms  XH3904Papillary tumour of the pineal region
http://id.who.int/icd/release/11/mms  XH2C49Diffuse astrocytoma, IDH-wildtype
http://id.who.int/icd/release/11/mms  XH2BA5Epithelioid glioblastoma
http://id.who.int/icd/release/11/mms  XH0ZP6Medulloblastoma, WNT-activated, NOS
http://id.who.int/icd/release/11/mms  XH5XD3Medulloblastoma, group 3
http://id.who.int/icd/release/11/mms  XH25R4Medulloblastoma, group 4
http://id.who.int/icd/release/11/mms  XH39Z7Astrocytoma, anaplastic, IDH-wildtype
http://id.who.int/icd/release/11/mms  XH17F8Diffuse low-grade glioma, MAPK pathway-altered
http://id.who.int/icd/release/11/mms  XH2SS9Diffuse hemispheric glioma, H3 G34-mutant
http://id.who.int/icd/release/11/mms  XH4Q01Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
http://id.who.int/icd/release/11/mms  XH4ZM8Infant-type hemispheric glioma
http://id.who.int/icd/release/11/mms  XH12D2Pilocytic astrocytoma
http://id.who.int/icd/release/11/mms  XH29Q5Pilomyxoid astrocytoma
http://id.who.int/icd/release/11/mms  XH41C5Angiocentric glioma
http://id.who.int/icd/release/11/mms  XH3Y57Atypical choroid plexus papilloma
http://id.who.int/icd/release/11/mms  XH7M44Desmoplastic infantile astrocytoma
http://id.who.int/icd/release/11/mms  XH6TQ7Desmoplastic infantile ganglioglioma
http://id.who.int/icd/release/11/mms  XH0B58Gliofibroma
http://id.who.int/icd/release/11/mms  XH6738Mixed subependymoma-ependymoma
http://id.who.int/icd/release/11/mms  XH15U1Myxopapillary ependymoma
http://id.who.int/icd/release/11/mms  XH1L48Subependymal giant cell astrocytoma
http://id.who.int/icd/release/11/mms  XH8FZ9Subependymoma
http://id.who.int/icd/release/11/mms  XH59V4Pituicytoma
http://id.who.int/icd/release/11/mms  XH9HV1Chordoid glioma
http://id.who.int/icd/release/11/mms  XH4101Chordoid glioma of third ventricle
http://id.who.int/icd/release/11/mms  XH09A9Granular cell tumour, NOS
http://id.who.int/icd/release/11/mms  XH2XW8Granular cell tumour of the sellar region
http://id.who.int/icd/release/11/mms  XH8V95Alveolar soft part sarcoma
http://id.who.int/icd/release/11/mms  XH90D3Granular cell tumour, malignant
http://id.who.int/icd/release/11/mms  XH2SJ1Fibrolipoma
http://id.who.int/icd/release/11/mms  XH0PH8Fibromyxolipoma
http://id.who.int/icd/release/11/mms  XH7TB0Infiltrating angiolipoma
http://id.who.int/icd/release/11/mms  XH5GN5Infiltrating lipoma
http://id.who.int/icd/release/11/mms  XH3TE0Intramuscular lipoma
http://id.who.int/icd/release/11/mms  XH30M7Pleomorphic lipoma
http://id.who.int/icd/release/11/mms  XH4E98Spindle cell lipoma
http://id.who.int/icd/release/11/mms  XH1PL8Lipoma, NOS
http://id.who.int/icd/release/11/mms  XH4G31Thymolipoma
http://id.who.int/icd/release/11/mms  XH3C77Angiolipoma, NOS
http://id.who.int/icd/release/11/mms  XH4VB4Angiomyolipoma
http://id.who.int/icd/release/11/mms  XH7WX8Chondroid lipoma
http://id.who.int/icd/release/11/mms  XH17C5Myelolipoma
http://id.who.int/icd/release/11/mms  XH1054Hibernoma
http://id.who.int/icd/release/11/mms  XH8L55Lipoblastomatosis
http://id.who.int/icd/release/11/mms  XH1C03Dedifferentiated liposarcoma
http://id.who.int/icd/release/11/mms  XH6R46Fibroblastic liposarcoma
http://id.who.int/icd/release/11/mms  XH7PE7Inflammatory liposarcoma
http://id.who.int/icd/release/11/mms  XH7Y61Liposarcoma, well differentiated
http://id.who.int/icd/release/11/mms  XH8VG3Mixed liposarcoma
http://id.who.int/icd/release/11/mms  XH3EL0Myxoid liposarcoma
http://id.who.int/icd/release/11/mms  XH25R1Pleomorphic liposarcoma
http://id.who.int/icd/release/11/mms  XH8D43Sclerosing liposarcoma
http://id.who.int/icd/release/11/mms  XH2J05Liposarcoma, NOS
http://id.who.int/icd/release/11/mms  XH0RW4Atypical lipomatous tumour
http://id.who.int/icd/release/11/mms  XH4QB6Lipofibromatosis
http://id.who.int/icd/release/11/mms  XH0QR3Angiomyolipoma, Epithelioid
http://id.who.int/icd/release/11/mms  XH9MR8Lymphangioma, NOS
http://id.who.int/icd/release/11/mms  XH6LF7Capillary lymphangioma
http://id.who.int/icd/release/11/mms  XH2EU7Cavernous lymphangioma
http://id.who.int/icd/release/11/mms  XH8G00Cystic lymphangioma
http://id.who.int/icd/release/11/mms  XH2DS9Lymphangiomyoma
http://id.who.int/icd/release/11/mms  XH62A3Haemolymphangioma
http://id.who.int/icd/release/11/mms  XH10U6Lymphangiosarcoma
http://id.who.int/icd/release/11/mms  XH10K6Lymphangiomyomatosis
http://id.who.int/icd/release/11/mms  XH5ZC7Fibrous meningioma
http://id.who.int/icd/release/11/mms  XH0R11Lymphoplasmacyte-rich meningioma
http://id.who.int/icd/release/11/mms  XH11P5Meningioma, NOS
http://id.who.int/icd/release/11/mms  XH40T5Meningothelial meningioma
http://id.who.int/icd/release/11/mms  XH7N06Metaplastic meningioma
http://id.who.int/icd/release/11/mms  XH1F70Microcystic meningioma
http://id.who.int/icd/release/11/mms  XH6Z51Secretory meningioma
http://id.who.int/icd/release/11/mms  XH3L73Haemangioblastic meningioma
http://id.who.int/icd/release/11/mms  XH4ZM7Psammomatous meningioma
http://id.who.int/icd/release/11/mms  XH6L68Angiomatous meningioma
http://id.who.int/icd/release/11/mms  XH4EX5Transitional meningioma
http://id.who.int/icd/release/11/mms  XH0324Meningioma, malignant
http://id.who.int/icd/release/11/mms  XH2NY9Papillary meningioma
http://id.who.int/icd/release/11/mms  XH6QS9Rhabdoid meningioma
http://id.who.int/icd/release/11/mms  XH5976Meningeal sarcomatosis
http://id.who.int/icd/release/11/mms  XH71V9Clear cell meningioma
http://id.who.int/icd/release/11/mms  XH2LS4Chordoid meningioma
http://id.who.int/icd/release/11/mms  XH1PF6Atypical meningioma
http://id.who.int/icd/release/11/mms  XH3SX7Adenoma of rete ovarii
http://id.who.int/icd/release/11/mms  XH5AH3Mesonephroma, benign
http://id.who.int/icd/release/11/mms  XH71B5Adenocarcinoma of rete ovarii
http://id.who.int/icd/release/11/mms  XH5WG5Mesonephroma, malignant
http://id.who.int/icd/release/11/mms  XH2WJ5Wolffian tumour
http://id.who.int/icd/release/11/mms  XH2VV6Fibrous mesothelioma, benign
http://id.who.int/icd/release/11/mms  XH1SS1Mesothelioma, benign
http://id.who.int/icd/release/11/mms  XH0KC4Epithelioid mesothelioma, benign
http://id.who.int/icd/release/11/mms  XH67N8Well differentiated papillary mesothelioma
http://id.who.int/icd/release/11/mms  XH8U12Peritoneal inclusion cysts
http://id.who.int/icd/release/11/mms  XH6BY3Adenomatoid tumour, NOS
http://id.who.int/icd/release/11/mms  XH54S8Fibrous mesothelioma, malignant
http://id.who.int/icd/release/11/mms  XH0XV0Mesothelioma, malignant
http://id.who.int/icd/release/11/mms  XH1DX8Mesothelioma, biphasic, malignant
http://id.who.int/icd/release/11/mms  XH0VP5Epithelioid mesothelioma, malignant
http://id.who.int/icd/release/11/mms  XH85T6Well differentiated papillary mesothelioma of the pleura
http://id.who.int/icd/release/11/mms  XH6M86Ossifying fibroma
http://id.who.int/icd/release/11/mms  XH23E0Aneurysmal bone cyst
http://id.who.int/icd/release/11/mms  XH8F52Adamantinoma of long bones
http://id.who.int/icd/release/11/mms  XH6C72Melanotic neuroectodermal tumour
http://id.who.int/icd/release/11/mms  XH7MT7Benign notochordal cell tumour
http://id.who.int/icd/release/11/mms  XH0S20Parachordoma
http://id.who.int/icd/release/11/mms  XH2S71Mixed pineal tumour
http://id.who.int/icd/release/11/mms  XH1S48Pineal parenchymal tumour of intermediate differentiation
http://id.who.int/icd/release/11/mms  XH1ZH1Pineoblastoma
http://id.who.int/icd/release/11/mms  XH3D20Transitional pineal tumour
http://id.who.int/icd/release/11/mms  XH7K24Neuroectodermal tumour, NOS
http://id.who.int/icd/release/11/mms  XH6P76Peripheral primitive neuroectodermal tumour
http://id.who.int/icd/release/11/mms  XH9GH0Chordoma, NOS
http://id.who.int/icd/release/11/mms  XH8KJ8Ewing sarcoma
http://id.who.int/icd/release/11/mms  XH0FH0Askin tumour
http://id.who.int/icd/release/11/mms  XH17D8Chondroid chordoma
http://id.who.int/icd/release/11/mms  XH7303Dedifferentiated chordoma
http://id.who.int/icd/release/11/mms  XH1AZ2Craniopharyngioma
http://id.who.int/icd/release/11/mms  XH15X9Craniopharyngioma, adamantinomatous
http://id.who.int/icd/release/11/mms  XH2BF0Craniopharyngioma, papillary
http://id.who.int/icd/release/11/mms  XH8QA9Pinealoma
http://id.who.int/icd/release/11/mms  XH1K94Pineocytoma
http://id.who.int/icd/release/11/mms  XH1J36Mucoepidermoid carcinoma
http://id.who.int/icd/release/11/mms  XH80V3Mucoepidermoid tumour
http://id.who.int/icd/release/11/mms  XH7CL0Angiomyoma
http://id.who.int/icd/release/11/mms  XH9824Bizarre leiomyoma
http://id.who.int/icd/release/11/mms  XH9662Cellular leiomyoma
http://id.who.int/icd/release/11/mms  XH8S79Epithelioid leiomyoma
http://id.who.int/icd/release/11/mms  XH4729Fetal rhabdomyoma
http://id.who.int/icd/release/11/mms  XH4FS5Lipoleiomyoma
http://id.who.int/icd/release/11/mms  XH1CZ1Myoma
http://id.who.int/icd/release/11/mms  XH4EP9Plexiform leiomyoma
http://id.who.int/icd/release/11/mms  XH4CY6Leiomyoma, NOS
http://id.who.int/icd/release/11/mms  XH9CC7Myxoid leiomyoma
http://id.who.int/icd/release/11/mms  XH8WG9Rhabdomyoma, NOS
http://id.who.int/icd/release/11/mms  XH4BG5Adult cellular rhabdomyoma
http://id.who.int/icd/release/11/mms  XH2736Glycogenic rhabdomyoma
http://id.who.int/icd/release/11/mms  XH5AF2Genital rhabdomyoma
http://id.who.int/icd/release/11/mms  XH8B88Leiomyoma, apoplectic
http://id.who.int/icd/release/11/mms  XH5Z76Leiomyoma, hydropic
http://id.who.int/icd/release/11/mms  XH5G84Cotyledonoid leiomyoma
http://id.who.int/icd/release/11/mms  XH6GV7Myolipoma
http://id.who.int/icd/release/11/mms  XH27W3Angiomyosarcoma
http://id.who.int/icd/release/11/mms  XH13Z5Epithelioid leiomyosarcoma
http://id.who.int/icd/release/11/mms  XH7ED4Leiomyosarcoma, NOS
http://id.who.int/icd/release/11/mms  XH08B3Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma
http://id.who.int/icd/release/11/mms  XH6YL0Mixed type rhabdomyosarcoma
http://id.who.int/icd/release/11/mms  XH8H07Myosarcoma
http://id.who.int/icd/release/11/mms  XH3122Myxoid leiomyosarcoma
http://id.who.int/icd/release/11/mms  XH5SX9Pleomorphic rhabdomyosarcoma, NOS
http://id.who.int/icd/release/11/mms  XH4VB5Pleomorphic rhabdomyosarcoma, adult type
http://id.who.int/icd/release/11/mms  XH0GA1Rhabdomyosarcoma, NOS
http://id.who.int/icd/release/11/mms  XH83G1Embryonal rhabdomyosarcoma, NOS
http://id.who.int/icd/release/11/mms  XH4749Embryonal rhabdomyosarcoma, pleomorphic
http://id.who.int/icd/release/11/mms  XH7V57Sarcoma botryoides
http://id.who.int/icd/release/11/mms  XH7NM2Spindle cell rhabdomyosarcoma
http://id.who.int/icd/release/11/mms  XH7099Alveolar rhabdomyosarcoma
http://id.who.int/icd/release/11/mms  XH0S12Ectomesenchymoma
http://id.who.int/icd/release/11/mms  XH60C2Intravascular leiomyomatosis

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code